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oblasts (MC3T3-E1) were treated with ionic products of bioactive glass dissolution (6P53-b experimental bioactive glass and 45S5 commercial Bioglass™). Results showed that gene expressions, including OCN and its up-stream transcription factors (Runx2, ATF4, MSX1, SP7/OSX), growth factors and signaling proteins (BMP2, BMP6, SMAD3), were enhanced in both 45S5 and 6P53-b glass conditioned mediums (GCMs). This up-regulation led to enhanced mineral formation by 45S5 glass conditioned mediums ( ) after 30 days. In examining the extracellular matrix generated by cells when exposed to each GCM, it was found that 45S5 GCM had slightly elevated levels of mineral content within ECM as compared to 6P53-b GCM after 30 days while control treatments exhibited no mineral content. The formation of well-defined mineralized nodules (distinct PO 4 3− [960 cm −1 ] and CO 3 2− [1072 cm −1 ] peaks from Raman Spectra) was observed for each GCM as the soluble glass content increased. In examining the individual and combined ion effects between Si , and Mg 2+ combinatorially regulate osteoblast OCN expression and biomineralization. © 2013 Elsevier B.V. All rights reserved.
Introduction
Stimulation of bone healing through enhanced osteogenesis is important in the treatment of osseous defects due to dental-related diseases. During bone healing, osteoblast progenitors (e.g., human periodontal ligament fibroblasts, bone marrow stromal cells) follow a prescribed timeline of gene expression and bone matrix development. At the later stages of bone matrix formation, osteocalcin (OCN) is expressed. OCN binds extracellular matrix calcium to the developing bone matrix [1] , and high serum levels are correlated with high bone mineral density [2, 3] . An in vitro model showed OCN expression occurred within the ECM after 18 days [4] , while endogenous expression occurred as early as 3 days after osteogenic induction [5] . Preceding or concurrent to OCN expression, other transcription factors, growth factors, and signaling proteins are expressed during osteoblast progenitor differentiation into the mineralizing phenotype. Therefore, bone regeneration strategies that up-regulate the expression of genes that promote enhanced OCN expression and osteoblast biomineralization are greatly desired.
Current dental regeneration therapies include biologically-based (autologous, allogeneic bone grafts) or synthetic (polymers, hydroxyapatite, titanium) treatments. However, each of these treatments has its own individual limitations. For example, biologically-based grafts can potentially compromise the patient's donor site or introduce disease to the patient [6] [7] [8] , while synthetic materials either lack sufficient strength, resorb too slowly, or do not bond directly to bone [9] . Moreover, these therapies can be rendered ineffective if they cannot treat the root cause of the patient's lack of generating new bone.
Materials Science and Engineering C 33 (2013) [2757] [2758] [2759] [2760] [2761] [2762] [2763] [2764] [2765] As an alternative, bioactive glasses are being used as a bone healing strategy [10] [11] [12] . The currently FDA approved glass for these applications is known as Perioglass™ (Mo-Sci, Rolla, MO) and is based on the chemistry of Hench's Bioglass™ (45S5, 45 wt.% SiO 2 , 24.5 wt.% Na 2 O, 24.5 wt.% CaO, 6 wt.% P 2 O 5 ). Although 45S5 has shown bone healing success in non-load bearing defects, it cannot be used in load-bearing applications (e.g., femoral, humeral, craniofacial bone replacements), which require structurally supporting, load bearing implants.
Saiz, and Tomsia and colleagues [13] [14] [15] [16] modified the composition of Bioglass™ for titanium implant coating applications by partially substituting CaO with MgO and Na 2 O with K 2 O (i.e., 6P53-b, 52.7 wt.% SiO 2 , 10.3 wt.% Na 2 O, 2.8 wt.% K 2 O, 18.0 wt.% CaO, 10.2 wt.% MgO, 6.0 wt.% P 2 O 5 ). These materials survive the coating process and form a chemical bond at the metal-glass interface. The advantages of these materials are that they can potentially be used in structural implants as a coating as well as defect filling implant applications. However, the particle concentration of this new family of bioactive glasses has not been elucidated to examine the potential enhancement of biomineralization in bone defect filling applications.
The osteogenic behavior between these glass materials could potentially differ because of their differing total ionic dissolution. Both 6P53-b and 45S5 glasses have an initial diffusion-controlled ion release mechanism that eventually becomes surface-reaction limited [17, 18] caused reduced osteogenic marker expression and reduced osteoblast differentiation [20] . Such an effect by Mg 2+ on OCN expression and subsequent biomineralization has not yet been studied and is explored in this work both individually and combinatorially as described previously [21] . The effect these ions have on osteoblast differentiation and mineralization will be studied using the osteoblast progenitors MC3T3-E1 subclone 4, which is a well-characterized cell line that lacks heterogeneity in phenotype that exist with primary cultures during differentiation. In addition, ion dissolution products and individual and combined ion treatments are tested at different dosages in the absence of glass surfaces to better determine their specific impact on OCN expression and biomineralization.
Therefore, it is hypothesized that Si 4+ and Ca 2+ combinatorial release by bioactive glass enhances osteoblast biomineralization through enhanced OCN expression, and Mg 2+ delays such enhancement. The aims of this study are (1) to determine the dose and temporal effect of ions released from bioactive coating glass and commercial Bioglass™ on OCN expression and biomineralization and (2) to determine if Mg 2+ down-regulates osteocalcin expression either individually or in combination with other ions that are released from bioactive glasses.
Materials and methods

Study design
Pertinent to the aims outlined above, bioactive glasses (45S5, 6P53-b) were prepared as a glass conditioned medium (GCM). Basal medium for MC3T3-E1 differentiation was used as a control. Temporal-and dose-dependent effects of GCM and control treatments on MC3T3-E1 OCN expression and biomineral synthesis were studied over the course of 30 days. mRNA lysates were assayed for gene expression using quantitative reverse transcriptase polymerase chain reaction (qRT-PCR, using glyceraldehyde phosphate (GAPDH) as an internal reference gene). Osteocalcin (OCN) expression from medium extracts and protein lysates was assayed using enzyme linked immunosorbent assay (ELISA). Visualization of biomineral formation was accomplished using histology (Alizarin red S stain), scanning electron microscopy (SEM), EDS, and Raman spectroscopy. Individual and combined ion effects of Ca 2+ , Si 4+ , and Mg 2+ were studied to delineate the specific individual and combined ion effects on osteoblast osteocalcin expression. Experiments were conducted with triplicate sampling and all experiments were repeated.
GCM preparation
Experimental bioactive coating glass (6P53-b, SEM-COM, Toledo, OH) and commercial Bioglass™ (45S5, Mo-Sci, East Rolla, and MO) were used in this study. These melt-derived glasses were ball milled and sieved into a microparticulate form (100-300 μm average particle diameters). 45S5 and 6P53-b glass samples were removed and ultrasonicated in acetone and 2-propanol, for subsequent drying overnight in a desiccator. The samples were then soaked in α-MEM (Invitrogen, Carlsbad, CA) at a volume to surface area ratio of 3 mL cm −2 within a capped centrifuge tube and stored in an incubator (37°C, 5% CO 2 , 100% RH) for 72 h. The loading concentration was 0.8, 1.6, and 2.4 g/glass per 50.0 mL. The medium was then collected as an ion extract, and sterile filtered (0.2 μm). Each ion extract was then supplemented (by volume) with 10% fetal bovine serum (FBS) and 1% penicillin-streptomycin (pen-strep) to make GCM. Individual ion treatments were prepared by dissolving 0. :Ca 2+ and then supplemented as described above. (Note: the inorganic sources for each ion were added at these specified concentrations such that their dissolved ion concentrations matched previously determined ion concentrations from bioactive glass dissolution [19] ).
Cell culture
MC3T3-E1 subclone 4 (ATCC, Manassus, VA) cells were seeded (50,000 cells cm −2 ) into 6-well plates. The plates were incubated overnight to allow for attachment and proliferation through their doubling time (38 h). Cells were then immersed in synchronization mediums (α-MEM, 1% FBS, 1% pen-strep) for 48 h. The synchronization mediums were removed and 45S5 and 6P53-b GCMs and basal mediums were added. All treatments were further supplemented with AA (50 ppm) and β-GP (10 mM) to induce differentiation. A parallel experiment was conducted in which cells were cultured on glass cover slips (not bioactive glasses) for ECM visualization. Visualization, gene expression, and protein expression assays were carried out over a 30 day time period. Individual and combined ion experiments were arranged in a similar manner, however, β-GP was not added and the time period of the experiments was fixed at 6 days.
To determine the dose dependence of these materials on osteocalcin and biomineral production, cells were cultured for 30 days in which protein lysates were measured for osteocalcin content and cells on cover slips were imaged biomineral formation.
qRT-PCR
In quantifying levels of gene expression, qRT-PCR was used. Cells cultured in each treatment were lysed at the time points specified above to collect mRNA (RNeasy Mini Kit, Qiagen, Valencia, CA) and converted to cDNA using reverse transcriptase (Reverse Transcription System, Promega, Madison, WI). cDNA samples were all diluted to a concentration of 100 ng μl −1 prior to PCR amplification. Reactions were executed using a real-time PCR machine (ABI7900, Applied Biosystems Inc., Foster City, CA). PCR amplification was evaluated using relative quantification by comparison to an internal housekeeping gene (glyceraldehyde 3-phosphate dehydrogenase or GAPDH). PCR amplification curves were collected using the SDS thermal cycler software package and regressed for their threshold cycle (C T ) using the sigmoidal curve fitting method [22] (SigmaPlot software package (Systat Software Inc., San Jose, CA)). Relative quantification of gene expression was evaluated using the ΔΔC T method (as described previously [21] ). Genes assayed in this work included osteocalcin (OCN) and its upstream transcription factors (core binding factor a1 (cbfa1/Runx2), activating transcription factor 4 (ATF4), Msh homeobox 1 (MSX1), osterix (SP7/OSX)), growth factors and signaling proteins (bone morphogenetic proteins 2 and 6 (BMP2, BMP6), mothers against decapentaplegic homologues 3 (SMAD3)).
ELISA
Protein expression was assayed from days 20-30. After mediums were removed and collected, cells were lysed to determine the relative expression of osteocalcin in both GCM and control cells. At the desired time point, cells were extracted from culture by removing mediums from cell layers, washing twice in PBS, and lysing cells (Cel-Lytic M, Sigma Inc., St. Louis, MO). Lysed cells were assayed for expressed osteocalcin using an enzyme-linked immunosorbent assay (ELISA, Biomedical Technologies, Inc., Boston, MA). Medium conditions were also assayed for unbound extracellular osteocalcin expression using ELISA.
Alizarin Red staining
Cells-on-cover slip samples were visualized for mineralized tissue formation using Alizarin Red staining (Sigma Inc., St. Louis, MO). This Alizarin Red stain forms insoluble orange-red lakes, identifying points of insoluble cations that are incorporated within mineralized tissue. At the above time points, samples were moved to a new 6-well plate, washed twice in PBS, and fixed with 10% formalin for 30-60 min. The samples were stained with Alizarin Red for 30 s to 5 min and washed with deionized water. Vigorous shaking removed any excess water from the samples, and the specimens underwent sequential alcohol dehydration (70-100% ethanol) for 2 min total. The samples were imaged by standard optical microscopy.
Raman/SEM imaging
Dehydrated samples from day 28 were mapped using microspot Raman spectroscopy (DXR, Thermo Scientific, 780 nm, 100 mW, 50 μm slit, 10 × objective, 10 s exposure). Thirty two spectra per location were recorded between 400 and 2000 cm 
Statistics
Statistical comparison of gene expression results was analyzed using GraphPad Prism 4. Two-way analysis of variance (ANOVA) followed by Bonferroni testing was used for an overall comparison of the independent factors, time and treatment, with the dependent factor, gene expression. For individual and combined ion studies, one-way ANOVA and Tukey's analysis were used for ion and control comparisons. Statistical comparisons shown are relative to corresponding control group and between GCM groups (indicated by bracket lines). A confidence level of p b 0.05 was used to report statistical significance. All data analyses were calculated from triplicate sampling per experiment.
Results
The effect of bioactive glass ion treatments on transcription factor expression
The transcription factors Runx2, ATF4, MSX1, and SP7/OSX (Fig. 1a,  b, c, and d, respectively) , were chosen for examination due to their involvement in osteoblastic differentiation and mineralization. The results showed a moderate enhancement of ATF4 (2.5-fold, Fig. 1b) and SP7 (2.5-fold, Fig. 1d ) gene expression by 45S5 GCM on day 6, while significant enhancement was seen by both 45S5 and 6P53-b GCMs on Runx2 (3.5-and 3-fold, respectively; Fig. 1a ) and MSX1 (3.5-and 5-fold, respectively; Fig. 1c ). 45S5 GCM also significantly increased Runx2 expression (7-fold, Fig. 1a ) on day 14. Significant differences in transcription factor gene expression were also observed between the GCMs. For example, 45S5 GCM induced moderately greater expression of Runx2, ATF4, and SP7 in MC3T3 cells compared to 6P53-b GCM; whereas, 6P53-b GCM resulted in greater expression of MSX1.
The effect of bioactive glass ion treatments on growth factors and signaling proteins
In our study, both 45S5 and 6P53-b GCMs resulted in an enhancement in the levels of growth factor and signaling protein (BMP2, BMP6, SMAD3) gene expression. For instance, BMP2 (Fig. 2a) was significantly enhanced (7.5-fold) in osteoblasts treated with 6P53-b GCM at day 6. The expression of BMP6 (Fig. 2b) was markedly enhanced by 45S5 GCM on day 6 (2-fold) and day 10 (21-fold). SMAD3 was found to be significantly enhanced by approximately 22-fold on day 2 and 7-fold on day 20 for 45S5 GCM treated cells (Fig. 2c) . For 6P53-b GCM treated cells, SMAD3 gene expression was enhanced approximately 2-fold on day 6 (Fig. 2c ). BMP2 and SMAD3 gene expressions were also statistically different between the GCMs, where 45S5 GCM resulted in greater gene expression levels in MC3T3 cells. The BMP2 gene, on the other hand, was expressed substantially more by MC3T3 cells treated with 6P53-b GCM compared to 45S5 GCM.
The effect of bioactive glass ion treatments on osteocalcin
Endogenous osteocalcin expression showed significant enhancement in 45S5 GCM treated cells on days 2 and 6 (12-and 46-fold, respectively; Fig. 3a ) while 6P53-b GCM treated cells induced increased expression at days 2 and 20 (4-fold, Fig. 3a) . Furthermore, our results showed that both GCM treatments up-regulated endogenous protein expression of OCN (Fig. 3b, (Fig. 3c,  3 -fold [6P53-b GCM], 5-fold [45S5 GCM]) and total overall protein yield (Fig. 3d) showed similar trends and reflected the results observed for endogenous OCN expression. In analyzing differences between the GCMs, gene and protein expressions of osteocalcin were found to be greater in 45S5 GCM treated cells relative to 6P53-b GCM treated cells at early time points and appeared to converge to similar levels towards day 30.
days 20-30 [45S5 GCM], days 24-30 [6P53-b GCM]). Extracellular OCN expression
The effect of bioactive glass ion treatments on mineralized tissue formation
Alizarin Red staining confirmed evidence of enhanced mineralized tissue formation by GCM treatments. The degree of redness represents the quantity of ECM Ca 2+ incorporation, thus illustrating the extent of mineralization. While control treated (Fig. 4a) and 6P53-b GCM treated cells (Fig. 4b) did not exhibit any degree of redness, 45S5 GCM treated cells showed a slight redness in their ECM on day 20 (Fig. 4c) . Moreover, while only a slight increase in the degree of redness occurred for control treated cells on day 30 (Fig. 4d) relative to day 20, a marked increase in redness occurred for 6P53-b GCM treated cells (Fig. 4e ) and 45S5 GCM treated cells (Fig. 4f) at day 30. 
The effect of Mg 2+ on Osteocalcin
For these studies, only AA was used to induce differentiation. β-GP, which releases phosphate ions, was not included in these latter studies to isolate the individual ionic effects without additional phosphate ions in each treatment. 
The effect of bioactive glass dose on OCN and biomineral synthesis
After 21 days in culture, it was found that OCN expression increased with increased bioactive glass particle concentration (Fig. 6 ). Significant increases in OCN expression for each GCM were observed at a particle concentration of 1.6 g/50 mL (0.032 g/mL). Although not significant for 6P53-b GCM at 2.4 g/50 mL (0.048 g/mL), an upward trend was still reported here.
At day 28, both 45S5 GCM and 6P53-b GCM treated cells showed EDS and Raman spectra indicative of mineral formation (Figs. 7-10 ). At the higher concentration levels (2.4 g/50 mL), distinct nodules were formed (Fig. 7b, d ) while the lowest concentration (0.8 g/50 mL) studied in both treatments showed evidence of both indistinct nodule formation and weak, dispersed mineral formation (Fig. 7a, c) . To compare the type of mineral formed, the ratio of the areas of the 1072 cm −1 carbonate band and the 960 cm −1 phosphate band was compared (Fig. 8) .
For the 0.8 g/50 mL treatments, only the nodule-like mineral was considered, rather than the less distinct mineral formations. Higher carbonate concentration, which is related to mineral maturity, was found to correlate with higher concentrations of GCM. Raman mapping of the 45S5 GCM treated samples also showed evidence of collagen formation (Fig. 9e) , while the control sample showed evidence of neither collagen nor mineral formation (Fig. 8f) . Similar results were obtained for the 6P53-b samples (Fig. 10 ).
Discussion
To address the aims of the study, we found that 45S5 GCM treatments out-performed 6P53-b GCM treatments in inducing early onset (≤ 20 days) of biomineralization, higher OCN gene expression, and higher up-stream gene expression of markers that regulate OCN expression. This difference was attributed to the release of Mg 2+ in 6P53-b GCM, which down-regulates OCN expression and dampened enhanced osteogenesis by Si 4+ and Ca
2+
. After 21-30 days, both GCM treatments out-performed control treatments in enhancing biomineralization and showed a dependence on bioactive glass particle concentration.
Early outperformance by 45S5 GCM as compared to 6P53-b GCM on biomineralization can be attributed to early enhanced OCN gene and protein expression. This early enhanced OCN gene expression was probably owed to early enhanced SMAD3 expression (day 2), which has been implicated in the promotion of mineralized tissue formation in MC3T3-E1 subclone 4 cells [23, 24] . Since OCN binds extracellular matrix Ca 2+ to the developing bone matrix, a lack of OCN up-regulation would inhibit enhanced biomineralization. This probably explains the delay in enhanced biomineralization tissue by 6P53-b GCM treated cells as compared to 45S5 GCM treated cells at day 20. Thus, the relative differences in initial biomineralization between each GCM treatment reflected the relative differences in enhanced early OCN expression. Although Mg 2+ is stored within bone and is important for bone remodeling [25] , it may down-regulate osteogenic gene expression. In this work, it was found that Mg 2+ induced a lack of OCN upregulation, which has not been previously shown in other studies of Mg 2+ on osteogenesis. Abed et al. [26] linked Mg 2+ to reduced osteoblast differentiation owed to the reduced expression of Runx2, which is partly involved in OCN regulation. Thus, the presence of Mg 2+ in 6P53-b GCM probably led to its under-performance in enhancing OCN expression at earlier time points. At later time points (> 21 days) and higher particle concentrations (> 0.08 g/50 mL), these relative differences between each GCM become smaller for OCN and biomineral content. Yet, the appearance of more developed and larger nodule in 45S5 GCM treated cells as compared to P53-b GCM treated cells indicates that this delay by Mg 2+ also impacts biomineralization. Interestingly, it was found here that the threshold value (0.08 g/50 mL) increased OCN expression while also increasing the rate of well-developed mineral. In previous work [21] , it was found that the increase in OCN expression is coupled to an increase in Si 4 + concentration; therefore, it is possible that a similar effect occurred in this work. Si 4 + release and silanol network formation follow the reaction proposed by Hench and colleagues [18] ,
In this generalized model, it is assume that the amorphous silica (SiO x ) is nearly stoichiometric (x = 2). As n increases, the spontaneously polymerized silanol network precipitates as a silica-gel layer. But, the formation of a silica-gel layer is insufficient to enhance biomineralization. It is the coupling of this effect with increased osteoblast OCN expression that binds with Ca and P to form mineral that is essential. Thus, the increased release of Si 4+ enhances biomineralization rate through the enhanced formation of a silica-gel layer and increased expression of the key Ca-binding protein, OCN. Interestingly, the increased 1072 cm ative of B-type carbonate apatite formation [27] . This result suggests that as the mineralized matrix matures with increasing bioactive glass particle concentration, more carbonate apatite is being incorporated. The increased presence of carbonate apatite is likely due to the probable increase in carbonate ion release from the higher bioactive glass particle concentrations. The improved maturation of the matrix (evidenced by more distinctive carbonate peak) is probably owed to the enhanced osteoblast activity associated with the likely increase in Si concentration (evidenced by increasing OCN expression with increasing bioactive glass particle concentration observed here and in previous work with Si alone [21] combinatorially enhanced OCN expression at levels between each of the individual ion treatments [21] . In this study, we showed that this Mg 2+ plays a down-regulatory role on OCN expression and dampens . Thus, these ions affect gene expression during osteoblast differentiation in accord with the combinatorial principle.
Based on our results, the use of 6P53-b would be suitable as an implant coating despite its delay in enhancing gene expression relative to 45S5. Since these materials bond well to the titanium surface and enhance osteogenesis, these materials would serve well in applications as an implant coating. Furthermore, these materials could be used to enhance bone defect healing. A threshold concentration (0.08 g/50 mL) yields relatively well-developed mineral formation. Still, it is worthy to note that such mineral is not as well developed as that of 45S5 and we attribute this to the presence of MgO in the glass and its associated dissolution leading to delays in OCN expression. This in vitro experiment thus illustrates the osteogenic potential of 6P53-b in the absence of ECM signals that arise during in vivo experiments or clinical application.
Since Mg 2+ may play a regulatory role on osteogenesis, it may be possible to use this feature in the development of new medical devices to control new bone formation. It is proposed here that multilayered bioactive glass designs could be used to take advantage of Mg 2+ release and regulation of osteogenesis. Biomaterials with multilayered membranes have been shown to be beneficial for controlling bone formation and remodeling [28, 29] . will be further investigated to determine if such control over new bone formation can be achieved.
Conclusions
Both 45S5 and 6p53-b glass conditioned mediums contained increased levels of ions as previously reported. These differences in ion concentrations led to enhanced gene expression of key osteogenic markers at various time points throughout osteoblast differentiation and mineralization. These genes include transcription factors, growth factors, and signaling proteins involved in OCN expression. 45S5 GCM treated cells were found to significantly up-regulate OCN expression and enhance biomineralization while 6P53-b GCM treated cells had a similar, but delayed and less pronounced effect. It was also found that as the bioactive glass particle concentration increased, the content of biomineral that remained carbonate-rich also increased.
This regulation of OCN and delayed biomineralization enhancement by 6P53-b GCM were attributed to the presence of Mg 2+ in 6P53-b GCM treatments. 
